Parabilis Medicines, Inc.
PBLS
$38.76
-$1.01-2.54%
NASDAQ
| 06/30/2026 | 03/31/2026 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.12B | 329.04M | -- | ||
| Total Receivables | -- | -- | -- | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 4.70M | 3.03M | -- | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | -- | -- | -- | ||
| Total Current Assets | 1.13B | 332.07M | -- | ||
|
|
|||||
| Total Current Assets | 1.13B | 332.07M | -- | ||
| Net Property, Plant & Equipment | 42.44M | 43.93M | -- | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | 7.43M | 8.17M | -- | ||
| Total Assets | 1.18B | 384.17M | -- | ||
|
|
|||||
| Total Accounts Payable | 18.53M | 15.04M | -- | ||
| Total Accrued Expenses | 14.35M | 16.36M | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | 13.97M | 17.43M | -- | ||
| Total Finance Division Other Current Liabilities | 16.00M | 5.41M | -- | ||
| Total Other Current Liabilities | 16.00M | 5.41M | -- | ||
| Total Current Liabilities | 62.84M | 54.24M | -- | ||
|
|
|||||
| Total Current Liabilities | 62.84M | 54.24M | -- | ||
| Long-Term Debt | -- | -- | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 33.54M | 35.71M | -- | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | 31.15M | 50.00M | -- | ||
| Total Liabilities | 127.53M | 139.95M | -- | ||
|
|
|||||
| Common Stock & APIC | 1.69B | 16.50M | -- | ||
| Retained Earnings | -639.28M | -586.82M | -- | ||
| Treasury Stock & Other | -18.00K | -- | -- | ||
| Total Common Equity | 1.05B | -570.32M | -- | ||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | 814.54M | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | -- | 814.54M | -- | ||
|
|
|||||
| Total Common Equity | 1.05B | -570.32M | -- | ||
| Total Preferred Equity | -- | 814.54M | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 1.05B | 244.22M | -- | ||
|
|
|||||